Emphysema or COPD Clinical Trial
Official title:
Measuring Collateral Ventilation Using Chartis® to Select Patients With Severe Emphysema for Endobronchial Valve Treatment: Conscious Sedation Versus General Anesthesia
Verified date | April 2019 |
Source | University Medical Center Groningen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Rationale: The Chartis® ( Pulmonx, CA, USA) measurement system is a tool to assess interlobar
collateral ventilation during bronchoscopy. Assessing collateral ventilation is important
when you intend to treat a patient with endobronchial valves. Chartis measurement of
collateral ventilation can be performed under both conscious sedation as well as general
anesthesia. There is no consensus on what is the preferred method of anesthesia for Chartis
measurements in the literature.
Objective: In this project we want to investigate whether there is a difference in Chartis
measurement outcomes between these two methods of anesthesia: conscious sedation and general
anesthesia.
Study design: This study will be a single center observational study
Study population: The study population exists of patients with severe emphysema who undergo
collateral ventilation assessment before bronchoscopic lung volume reduction treatment with
one-way endobronchial valves.
Intervention: All patients will undergo two subsequent Chartis measurements. The first
measurement will be performed with the patient undergoing conscious sedation and the second
measurement with the patient under general anesthesia.
Main study parameters/endpoints: Our primary outcome measure is the failure rate of the
Chartis collateral ventilation measurement under general anesthesia versus conscious
sedation.
Status | Completed |
Enrollment | 30 |
Est. completion date | January 22, 2019 |
Est. primary completion date | January 22, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves - Patient has provided signed informed consent. Exclusion Criteria: For safety reasons patients that meet the following criteria will not be included in this study: 1. FEV1 <20% 2. RV/TLC>70% 3. pCO2 >6.5 4. RVSP>40mmHg 5. 6MWT<200m 6. Known intolerance to Lidocaine 7. Any other medical reason/condition that warrants a short procedure (physician judgement ) |
Country | Name | City | State |
---|---|---|---|
Netherlands | University Medical Center Groningen | Groningen |
Lead Sponsor | Collaborator |
---|---|
University Medical Center Groningen |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Failure rate | The failure rate of the Chartis collateral ventilation measurement under general anesthesia versus conscious sedation. | Baseline | |
Secondary | Chartis measurement duration | To compare the duration of Chartis measurement in patients undergoing conscious sedation versus general anesthesia. | Baseline | |
Secondary | Physician feasibility | To investigate qualitative assessment feasibility for the physician in patients undergoing conscious sedation or general anesthesia. | Baseline | |
Secondary | Influence severity on outcome | To investigate the influence of severity of disease in patients undergoing conscious sedation or general anesthesia. | Baseline | |
Secondary | Influence collateral ventilation status on outcome | To investigate outcome difference in collateral ventilation status in patients undergoing conscious sedation versus general anesthesia | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
Recruiting |
NCT03285100 -
The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation
|
N/A | |
Not yet recruiting |
NCT05900544 -
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
|
N/A | |
Recruiting |
NCT06163131 -
The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility
|
||
Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
Recruiting |
NCT05854550 -
First in Human Study to Assess an Implant to Treat Severe Emphysema
|
N/A | |
Recruiting |
NCT05257681 -
Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
|
N/A | |
Recruiting |
NCT06068647 -
Ultrasound and Respiratory Physiological Signals in Lung Diseases
|
N/A | |
Recruiting |
NCT03318406 -
Post-Market BTVA Registry
|
||
Recruiting |
NCT04214587 -
Biological Investigation of Explanted Endobronchial Lung Valves Study
|
||
Recruiting |
NCT04781582 -
LVRS Versus BLVR in Patients With Homogenous Emphysema, CLUB-HE Trial
|
N/A | |
Completed |
NCT04520152 -
Evaluation of the Free Flow Medical Lung Tensioning Device System for the Treatment of Severe Emphysema
|
N/A | |
Recruiting |
NCT03680495 -
Steroid Resistance During COPD Exacerbations With Respiratory Failure
|
||
Active, not recruiting |
NCT04517916 -
Zephyr Etude Post-Inscription (French Registry)
|
||
Recruiting |
NCT06249529 -
Airway Bypass - Safety and Feasibility Study
|
Early Phase 1 | |
Recruiting |
NCT06035120 -
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
|
N/A | |
Recruiting |
NCT05567562 -
Anti-Platelets in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Withdrawn |
NCT04029077 -
Introduction of the Vapor Treatment in The Netherlands
|
||
Recruiting |
NCT03755505 -
The Microbiome of Sputum, Urine and Feces in Healthy Persons and Chronic Obstructive Pulmonary Disease (COPD) Patients
|
||
Completed |
NCT03670121 -
A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP)
|
N/A |